Literature DB >> 30281328

Dusting Off IL-9 as a New Therapeutic Target for Pulmonary Fibrosis.

Joselyn Rojas-Quintero1, Xiaoyun Wang1, Caroline A Owen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30281328      PMCID： PMC6376410          DOI： 10.1165/rcmb.2018-0319ED

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   7.748


× No keyword cloud information.
  15 in total

Review 1.  Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.

Authors:  John Hutchinson; Andrew Fogarty; Richard Hubbard; Tricia McKeever
Journal:  Eur Respir J       Date:  2015-05-14       Impact factor: 16.671

Review 2.  Genetically manipulated mouse models of lung disease: potential and pitfalls.

Authors:  Rebecca M Baron; Alexander J S Choi; Caroline A Owen; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-23       Impact factor: 5.464

Review 3.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

4.  Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair.

Authors:  Maciej Lech; Hans-Joachim Anders
Journal:  Biochim Biophys Acta       Date:  2012-12-13

5.  Identification of early interstitial lung disease in smokers from the COPDGene Study.

Authors:  George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu
Journal:  Acad Radiol       Date:  2009-09-24       Impact factor: 3.173

6.  Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.

Authors:  Laurie Whittaker; Naiqian Niu; U-Angela Temann; Amy Stoddard; Richard A Flavell; Anuradha Ray; Robert J Homer; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2002-11       Impact factor: 6.914

7.  IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice.

Authors:  Naoya Sugimoto; Maho Suzukawa; Hiroyuki Nagase; Yuta Koizumi; Shoki Ro; Konomi Kobayashi; Hisanao Yoshihara; Yasuhiro Kojima; Asae Kamiyama-Hara; Akira Hebisawa; Ken Ohta
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

Review 8.  Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.

Authors:  William J Canestaro; Sara H Forrester; Ganesh Raghu; Lawrence Ho; Beth E Devine
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410

9.  A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma.

Authors:  Chad K Oh; Richard Leigh; Kimmie K McLaurin; Keunpyo Kim; Micki Hultquist; Nestor A Molfino
Journal:  Respir Res       Date:  2013-09-19

10.  A deleterious role for Th9/IL-9 in hepatic fibrogenesis.

Authors:  Shan-yu Qin; Dong-hong Lu; Xiao-yun Guo; Wei Luo; Bang-li Hu; Xiao-li Huang; Mei Chen; Jia-xu Wang; Shi-Jia Ma; Xian-wen Yang; Hai-xing Jiang; You Zhou
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379
View more
  1 in total

Review 1.  Update in Interstitial Lung Disease 2019.

Authors:  Sydney B Montesi; Jolene H Fisher; Fernando J Martinez; Moisés Selman; Annie Pardo; Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.